Overview

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

Status:
Completed
Trial end date:
2009-08-20
Target enrollment:
Participant gender:
Summary
This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Naproxen
Sumatriptan